Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
Open Access
- 27 May 1998
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 279 (20) , 1615-1622
- https://doi.org/10.1001/jama.279.20.1615
Abstract
EPIDEMIOLOGICAL observations have demonstrated consistently a strong positive, continuous, independent, graded relation between plasma total cholesterol (TC) and the incidence of coronary heart disease (CHD). This relation covers a wide range of cholesterol concentrations, including those considered normal or mildly elevated.1-3 In the Multiple Risk Factor Intervention Trial follow-up of screened men, 69% of deaths from CHD in the first 6 years of follow-up occurred in subjects with TC values between 4.71 and 6.83 mmol/L (182-264 mg/dL).4 In the first 16 years of the Framingham Heart Study, 40% of participants who developed a myocardial infarction had a TC level between 5.17 and 6.47 mmol/L (200-250 mg/dL).5Keywords
This publication has 7 references indexed in Scilit:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.BMJ, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemiaArchives of internal medicine (1960), 1991
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987